W J Burke

Summary

Affiliation: University of Nebraska Medical Center
Country: USA

Publications

  1. pmc Alpha-2 adrenergic-induced changes in rectal temperature in adult and 13-day old rats following acute and repeated desipramine administration
    Jean D Deupree
    Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, 985800 Nebraska Medical Center, Omaha, NE 68198 5800 USA
    BMC Pharmacol 8:17. 2008
  2. ncbi request reprint The reliability and validity of the collateral source version of the Geriatric Depression Rating Scale administered by telephone
    W J Burke
    Creighton Nebraska Department of Psychiatry, University of Nebraska Medical Center, Omaha, USA
    Int J Geriatr Psychiatry 12:288-94. 1997
  3. ncbi request reprint Escitalopram: better treatment for depression is through the looking glass
    Paulajo Malin
    Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE 68198 5580, USA
    Expert Rev Neurother 4:769-79. 2004
  4. ncbi request reprint Selective versus multi-transmitter antidepressants: are two mechanisms better than one?
    William J Burke
    Department of Psychiatry, University of Nebraska, Nebraska Medical Center, Omaha 68198 5580, USA
    J Clin Psychiatry 65:37-45. 2004
  5. ncbi request reprint Late-life mood disorders
    William J Burke
    Department of Psychiatry, University of Nebraska Medical Center, 985580 Nebraska Medical Center, Omaha, NE 68198 5580, USA
    Clin Geriatr Med 19:777-97, vii. 2003
  6. ncbi request reprint Escitalopram
    William J Burke
    University of Nebraska Department of Psychiatry, 985580 Nebraska Medical Center, Omaha, NE 68198 5580, USA
    Expert Opin Investig Drugs 11:1477-86. 2002
  7. ncbi request reprint Exploring treatment alternatives: weekly dosing of fluoxetine for the continuation phase of major depressive disorder
    W J Burke
    University of Nebraska Medical Center, Department of Psychiatry, Omaha 68198 5580, USA
    J Clin Psychiatry 62:38-42. 2001
  8. ncbi request reprint The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia
    W J Burke
    Creighton Nebraska Department of Psychiatry, University of Nebraska Medical Center, Omaha, USA
    Int J Geriatr Psychiatry 12:519-25. 1997
  9. ncbi request reprint Disagreement in the reporting of depressive symptoms between patients with dementia of the Alzheimer type and their collateral sources
    W J Burke
    Department of Psychiatry, University of Nebraska College of Medicine, Omaha, USA
    Am J Geriatr Psychiatry 6:308-19. 1998
  10. ncbi request reprint Weekly dosing of fluoxetine for the continuation phase of treatment of major depression: results of a placebo-controlled, randomized clinical trial
    W J Burke
    Psychopharmacology Research Center, University of Nebraska Department of Psychiatry, University of Nebraska Medical Center, Omaha 68198 5580, USA
    J Clin Psychopharmacol 20:423-7. 2000

Detail Information

Publications35

  1. pmc Alpha-2 adrenergic-induced changes in rectal temperature in adult and 13-day old rats following acute and repeated desipramine administration
    Jean D Deupree
    Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, 985800 Nebraska Medical Center, Omaha, NE 68198 5800 USA
    BMC Pharmacol 8:17. 2008
    ..The change in the extent of the brimonidine-induced hypothermia following pretreatment with either single or 4 twice-daily injections of desipramine was compared in 13-day old and adult (65-75 days old) male rats...
  2. ncbi request reprint The reliability and validity of the collateral source version of the Geriatric Depression Rating Scale administered by telephone
    W J Burke
    Creighton Nebraska Department of Psychiatry, University of Nebraska Medical Center, Omaha, USA
    Int J Geriatr Psychiatry 12:288-94. 1997
    ..To prospectively evaluate the reliability and validity of the Collateral Source Geriatric Depression Scale (CS-GDS) administered by telephone (T-CS-GDS) in patients undergoing outpatient comprehensive geriatric assessment...
  3. ncbi request reprint Escitalopram: better treatment for depression is through the looking glass
    Paulajo Malin
    Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE 68198 5580, USA
    Expert Rev Neurother 4:769-79. 2004
    ..It has also shown efficacy in treating panic disorder and generalized and social anxiety disorders. This is advantageous as many patients who suffer from depression also experience comorbid anxiety disorders...
  4. ncbi request reprint Selective versus multi-transmitter antidepressants: are two mechanisms better than one?
    William J Burke
    Department of Psychiatry, University of Nebraska, Nebraska Medical Center, Omaha 68198 5580, USA
    J Clin Psychiatry 65:37-45. 2004
    ..This review should caution one in accepting claims of superiority of any agent based on purported mechanism of action...
  5. ncbi request reprint Late-life mood disorders
    William J Burke
    Department of Psychiatry, University of Nebraska Medical Center, 985580 Nebraska Medical Center, Omaha, NE 68198 5580, USA
    Clin Geriatr Med 19:777-97, vii. 2003
    ..Also included is a discussion of risk factors and outcomes of these disorders...
  6. ncbi request reprint Escitalopram
    William J Burke
    University of Nebraska Department of Psychiatry, 985580 Nebraska Medical Center, Omaha, NE 68198 5580, USA
    Expert Opin Investig Drugs 11:1477-86. 2002
    ..Only nausea occurred in > 10% of escitalopram-treated patients...
  7. ncbi request reprint Exploring treatment alternatives: weekly dosing of fluoxetine for the continuation phase of major depressive disorder
    W J Burke
    University of Nebraska Medical Center, Department of Psychiatry, Omaha 68198 5580, USA
    J Clin Psychiatry 62:38-42. 2001
    ..It is proposed that less frequent dosing could potentially benefit patients by enhancing adherence and minimizing the risk of side effects and drug-drug interactions...
  8. ncbi request reprint The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia
    W J Burke
    Creighton Nebraska Department of Psychiatry, University of Nebraska Medical Center, Omaha, USA
    Int J Geriatr Psychiatry 12:519-25. 1997
    ....
  9. ncbi request reprint Disagreement in the reporting of depressive symptoms between patients with dementia of the Alzheimer type and their collateral sources
    W J Burke
    Department of Psychiatry, University of Nebraska College of Medicine, Omaha, USA
    Am J Geriatr Psychiatry 6:308-19. 1998
    ..CSs consistently perceived more depressive symptoms than subjects, especially subjects with DAT who had no insight into their cognitive impairment...
  10. ncbi request reprint Weekly dosing of fluoxetine for the continuation phase of treatment of major depression: results of a placebo-controlled, randomized clinical trial
    W J Burke
    Psychopharmacology Research Center, University of Nebraska Department of Psychiatry, University of Nebraska Medical Center, Omaha 68198 5580, USA
    J Clin Psychopharmacol 20:423-7. 2000
    ..Weekly dosing of FLX seems to be well tolerated and possibly as effective as daily dosing in maintaining the therapeutic response in subjects with MDD...
  11. ncbi request reprint Antidepressants augment natural killer cell activity: in vivo and in vitro
    M G Frank
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebr, USA
    Neuropsychobiology 39:18-24. 1999
    ....
  12. ncbi request reprint Levels of monocyte reactive oxygen species are associated with reduced natural killer cell activity in major depressive disorder
    M G Frank
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 6495, USA
    Neuropsychobiology 44:1-6. 2001
    ....
  13. ncbi request reprint Clinical response augments NK cell activity independent of treatment modality: a randomized double-blind placebo controlled antidepressant trial
    M G Frank
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
    Psychol Med 34:491-8. 2004
    ..The present investigation examined the effect of antidepressant treatment on NKCA utilizing a randomized double-blind placebo controlled experimental design...
  14. doi request reprint New onset multimodal hallucinations associated with mirtazapine: a case report
    Kalpana P Padala
    Department of Family Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198 3075, USA
    Int Psychogeriatr 22:837-9. 2010
    ..We report three cases of auditory, musical and visual hallucinations associated with the use of mirtazapine...
  15. ncbi request reprint Modafinil therapy for apathy in an elderly patient
    Prasad R Padala
    Omaha Veterans Affairs Medical Center, Omaha, NE, USA
    Ann Pharmacother 41:346-9. 2007
    ..To present a case of successful treatment of apathy syndrome with modafinil...
  16. ncbi request reprint Treatment of apathy with methylphenidate
    Prasad R Padala
    Veterans Affairs Medical Center, 4101 Woolworth Avenue, Omaha, NE 68105, USA
    J Neuropsychiatry Clin Neurosci 19:81-3. 2007
    ..Its treatment is not well studied. The authors present four cases of apathy treated with a regimen of methylphenidate. Significant improvement in apathy and its sub-domains (motivation, novelty, and persistence) were noted...
  17. pmc Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies
    Megan E Kozisek
    Department of Pharmacology and Experimental Neuroscience, 985800 Nebraska Medical Center, University of Nebraska Medical Center, Omaha, NE 68198 5800, USA
    J Neurosci Methods 163:83-91. 2007
    ..Thus, the pharmacokinetic properties of DMI varies with the age of the animal and dosing of DMI and needs to be carefully adjusted in order to have appropriate brain levels of the drug...
  18. doi request reprint A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer
    William M Lydiatt
    Department of Otolaryngology Head and Neck Surgery, University of Nebraska Medical Center, Omaha, NE 68198 1225, USA
    Arch Otolaryngol Head Neck Surg 134:528-35. 2008
    ..To determine whether prophylactic treatment with the antidepressant citalopram hydrobromide, compared with placebo, could prevent major depressive disorder in patients undergoing therapy for head and neck cancer (HNC)...
  19. ncbi request reprint A review of depression in the head and neck cancer patient
    William M Lydiatt
    Department of Otolaryngology and Head and Neck Surgery, University of Nebraska Medical Center, Omaha, NE 68198 1225, USA
    Clin Adv Hematol Oncol 7:397-403. 2009
    ..Treatment can be successful and typically involves medical, social, and psychologic interventions. Causes of depression, obtaining an accurate diagnosis, and treatment options are all discussed in this review...
  20. doi request reprint Methylphenidate for apathy and functional status in dementia of the Alzheimer type
    Prasad R Padala
    Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE, USA
    Am J Geriatr Psychiatry 18:371-4. 2010
    ..Treatment of apathy in DAT is not systematically studied. The purpose of this study was to evaluate the response of apathy to methylphenidate treatment and to examine whether functional status improved...
  21. ncbi request reprint Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable?
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, Nebraska 68198, USA
    J Child Adolesc Psychopharmacol 16:11-24. 2006
    ..The authors have concluded that SSRIs -- in particular, fluoxetine -- do have a role in the treatment of pediatric depression...
  22. ncbi request reprint Atomoxetine in the treatment of attention deficit hyperactivity disorder
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, NE 68198 5581, USA
    Expert Rev Neurother 4:601-11. 2004
    ..This article reviews the available information on atomoxetine, accompanied by a discussion of its clinical use...
  23. ncbi request reprint Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients
    William J Burke
    Department of Psychiatry, University of Nebraska Medical Center, Omaha 68198 5580, USA
    J Clin Psychiatry 63:331-6. 2002
    ..The present randomized, double-blind, placebo-controlled, fixed-dose multicenter trial was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of major depressive disorder...
  24. ncbi request reprint Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder
    Christopher J Kratochvil
    Department of Psychiatry, University of Nebraska Medical Center, Omaha 68191 5581, USA
    Expert Opin Pharmacother 4:1165-74. 2003
    ..Atomoxetine is the first nonstimulant approved by the FDA for the treatment of ADHD and the first medication approved for the treatment of adult ADHD...
  25. ncbi request reprint Pharmacotherapy of childhood anxiety disorders
    Christopher J Kratochvil
    Department of Child and Adolescent Psychiatry, University of Nebraska Medical Center, 44th and Emile, Omaha, NE 68198, USA
    Curr Psychiatry Rep 4:264-9. 2002
    ..This article will review significant pharmacologic studies published in the prior year, and the role of pharmacotherapy in the treatment of pediatric anxiety disorders...
  26. ncbi request reprint Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Biol Psychiatry 58:347-54. 2005
    ..Vagus nerve stimulation (VNS) alters both concentrations of neurotransmitters or their metabolites and functional activity of central nervous system regions dysregulated in mood disorders. An open trial has suggested efficacy...
  27. doi request reprint Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial
    Kathryn E Lazure
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Head Neck 31:888-92. 2009
    ..Thirty-five patients were randomized, 34 with 1 or more evaluations form the basis of this report...
  28. ncbi request reprint The unreliable informant. Bad information hinders appropriate patient care
    Dennis P McNeilly
    Department of Psychiatry, Division of Geriatric Psychiatry, University of Nebraska College of Medicine, Omaha, USA
    Geriatrics 57:60-2. 2002
  29. ncbi request reprint The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, Nebraska 68198 5581, USA
    CNS Drugs 18:957-66. 2004
    ....
  30. ncbi request reprint An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder
    C J Kratochvil
    Department of Psychiatry, University of Nebraska Medical Center, Omaha 68191 5581, USA
    J Child Adolesc Psychopharmacol 11:167-70. 2001
    ..To collect pilot data assessing the safety, tolerability, and efficacy of tomoxetine, a nonstimulant norepinephrine enhancer, in pediatric attention deficit hyperactivity disorder (ADHD)...
  31. ncbi request reprint Neuroleptic sensitivity to clozapine in dementia with Lewy bodies
    W J Burke
    Department of Psychiatry, University of Nebraska Medical Center, Omaha, USA
    J Neuropsychiatry Clin Neurosci 10:227-9. 1998
    ..The authors describe 2 patients with DLB who were intolerant of clozapine, showing not extrapyramidal side effects, but an increase in confusion and behavioral symptoms...
  32. ncbi request reprint Age at onset of major depressive disorder predicts reductions in NK cell number and activity
    Matthew G Frank
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA
    J Affect Disord 71:159-67. 2002
    ..The present study addressed the question of whether age at onset of index episode and/or duration of the present episode of MDD predicted alterations in NKCA and NK cell number...
  33. ncbi request reprint Diagnosis and treatment of alcohol dependence in older alcoholics
    S Pirzada Sattar
    Department of Psychiatry, Creighton University School of Medicine, Omaha Veteran s Administration Medical Center, University of Nebraska School of Medicine, Omaha, NE, USA
    Clin Geriatr Med 19:743-61. 2003
    ..Research is necessary to explore the benefits of alcohol treatments in elderly patients. Until then, adherence to these recommendations should be the best available approach...
  34. ncbi request reprint The impact of apathy on glycemic control in diabetes: a cross-sectional study
    Prasad R Padala
    Veterans Affairs Medical Center, Omaha, NE 68105, USA
    Diabetes Res Clin Pract 79:37-41. 2008
    ..The secondary objective was to determine if there was an association between clinically significant apathy and factors that affect glycemic control...
  35. ncbi request reprint Impact of problem alcohol use on patient behavior and caregiver burden in a geriatric assessment clinic
    S Pirzada Sattar
    Substance Abuse Treatment Program, Omaha VA Medical Center, Nebraska, USA
    J Geriatr Psychiatry Neurol 20:120-7. 2007
    ..A history of problem drinking appears to be a significant marker for behavioral disturbances in late life and merits further study...

Research Grants4

  1. Prevention of Depression in Patients Being Treated for Head and Neck Cancer
    William Burke; Fiscal Year: 2007
    ..If successful, this approach may be applicable to other medical illnesses that have high rates of comorbid depression. ..
  2. Prevention of Depression in Patients Being Treated for Head and Neck Cancer
    William Burke; Fiscal Year: 2009
    ..If successful, this approach may be applicable to other medical illnesses that have high rates of comorbid depression. ..
  3. Prevention of Depression in Patients Being Treated for Head and Neck Cancer
    William J Burke; Fiscal Year: 2010
    ..If successful, this approach may be applicable to other medical illnesses that have high rates of comorbid depression. ..